The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs
Open accessAbstract
The rapid emergence of multidrug-resistant pathogens has evolved into a global health problem as current treatment options are failing for infections caused by pan-resistant bacteria. Hence, novel antibiotics are in high demand, and for this reason antimicrobial peptides (AMPs) have attracted considerable interest, since they often show broad-spectrum activity, fast killing and high cell selectivity. However, the therapeutic potential of natural AMPs is limited by their short plasma half-life. Antimicrobial peptidomimetics mimic the structure and biological activity of AMPs, but display extended stability in the presence of biological matrices. In the present review, focus is on the developments reported in the last decade with respect to their design, synthesis, antimicrobial activity, cytotoxic side effects as well as their potential applications as anti-infective agents. Specifically, only peptidomimetics with a modular structure of residues connected via amide linkages will be discussed. These comprise the classes of α-peptoids (N-alkylated glycine oligomers), β-peptoids (N-alkylated β-alanine oligomers), β3-peptides, α/β3-peptides, α-peptide/β-peptoid hybrids, α/γ N-acylated N-aminoethylpeptides (AApeptides), and oligoacyllysines (OAKs). Such peptidomimetics are of particular interest due to their potent antimicrobial activity, versatile design, and convenient optimization via assembly by standard solid-phase procedures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
(2016) · Cited by 2,888
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture
Cory, A. H., Owen, T. C., Barltrop, J. A., & Cory, J. G. (1991) · Cancer Communications · doi:10.3727/095535491820873191 · Cited by 1,519
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Horizontal gene transfer in eukaryotic evolution
Keeling, P. J., & Palmer, J. D. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2386 · Cited by 1,355
Zuckermann, R. N., Kerr, J. M., Kent, S. B. H., & Moos, W. H. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00052a076 · Cited by 1,277
Katayama, Y., Ito, T., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1549-1555.2000 · Cited by 1,038
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Describing the Mechanism of Antimicrobial Peptide Action with the Interfacial Activity Model
Wimley, W. C. (2010) · ACS Chemical Biology · doi:10.1021/cb1001558 · Cited by 1,001
Peptoids: a modular approach to drug discovery.
Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., & Marlowe, C. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9367 · Cited by 953
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 845
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
β-Peptides: a surprise at every turn
Seebach, D., & Matthews, J. L. (1997) · Chemical Communications · doi:10.1039/a704933a · Cited by 782
Xavier, B. B., Lammens, C., Ruhal, R., Kumar-Singh, S., Butaye, P., Goossens, H., & Malhotra-Kumar, S. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.27.30280 · Cited by 779
Action of Antimicrobial Peptides: Two-State Model
Huang, H. W. (2000) · Biochemistry · doi:10.1021/bi000946l · Cited by 740
Antimicrobial Peptides: Mechanisms of Action and Resistance
Bechinger, B., & Gorr, S.-U. (2017) · Journal of Dental Research · doi:10.1177/0022034516679973 · Cited by 739
Wu, M., Maier, E., Benz, R., & Hancock, R. E. W. (1999) · Biochemistry · doi:10.1021/bi9826299 · Cited by 736
Carbapenem resistance: overview of the problem and future perspectives
Meletis, G. (2016) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115621709 · Cited by 725
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
Bacteriocins: Biological tools for bio-preservation and shelf-life extension
Deegan, L. H., Cotter, P. D., Hill, C., & Ross, P. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2005.10.026 · Cited by 682
Non-haemolytic β-amino-acid oligomers
Porter, E. A., Wang, X., Lee, H.-S., Weisblum, B., & Gellman, S. H. (2000) · Nature · doi:10.1038/35007145 · Cited by 671
Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides
Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., & Barron, A. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708254105 · Cited by 657
Tew, G. N., Scott, R. W., Klein, M. L., & DeGrado, W. F. (2010) · Accounts of Chemical Research · doi:10.1021/ar900036b · Cited by 552
Peptoid Polymers: A Highly Designable Bioinspired Material
Sun, J., & Zuckermann, R. N. (2013) · ACS Nano · doi:10.1021/nn4015714 · Cited by 457
Johnson, A. P., & Woodford, N. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.052555-0 · Cited by 411
Mimicry of Host-Defense Peptides by Unnatural Oligomers: Antimicrobial β-Peptides
Porter, E. A., Weisblum, B., & Gellman, S. H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0260871 · Cited by 379
Antimicrobial peptides of the genus Bacillus: a new era for antibiotics
Sumi, C. D., Yang, B. W., Yeo, I.-C., & Hahm, Y. T. (2015) · Canadian Journal of Microbiology · doi:10.1139/cjm-2014-0613 · Cited by 379
From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides
Shai, Y., & Oren, Z. (2001) · Peptides · doi:10.1016/s0196-9781(01)00498-3 · Cited by 370
Antimicrobial Peptides: Properties and Applicability
Hof, W. V. T., Veerman, E. C. I., Helmerhorst, E. J., & Amerongen, A. V. N. (2001) · Biological Chemistry · doi:10.1515/bc.2001.072 · Cited by 354
Antibiotics in the clinical pipeline at the end of 2015
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.72 · Cited by 349
De Novo Design of Antibacterial β-Peptides
Hamuro, Y., Schneider, J. P., & DeGrado, W. F. (1999) · Journal of the American Chemical Society · doi:10.1021/ja992728p · Cited by 345
De Novo Design, Synthesis, and Characterization of Antimicrobial β-Peptides
Liu, D., & DeGrado, W. F. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0107475 · Cited by 339
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
Lipsky, B. A., Holroyd, K. J., & Zasloff, M. (2008) · Clinical Infectious Diseases · doi:10.1086/593185 · Cited by 324
Antimicrobial peptide mimics for improved therapeutic properties
Rotem, S., & Mor, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.020 · Cited by 296
Antimicrobial Peptides: An Introduction
Haney, E. F., Mansour, S. C., & Hancock, R. E. W. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6737-7_1 · Cited by 296
Fowler, S. A., & Blackwell, H. E. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b817980h · Cited by 292
Antimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens
(2006) · Current Issues in Molecular Biology · doi:10.21775/cimb.008.011 · Cited by 289
Harrison, J. J., Stremick, C. A., Turner, R. J., Allan, N. D., Olson, M. E., & Ceri, H. (2010) · Nature Protocols · doi:10.1038/nprot.2010.71 · Cited by 286
Peptidomimetics via modifications of amino acids and peptide bonds
Avan, I., Hall, C. D., & Katritzky, A. R. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60384a · Cited by 283
An overview of antimicrobial peptides and the latest advances in their development
Sierra, J. M., Fusté, E., Rabanal, F., Vinuesa, T., & Viñas, M. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1315402 · Cited by 283
Review on methicillin-resistant Staphylococcus pseudintermedius
van Duijkeren, E., Catry, B., Greko, C., Moreno, M. A., Pomba, M. C., Pyorala, S., Ruzauskas, M., Sanders, P., Threlfall, E. J., Torren-Edo, J., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr367 · Cited by 275
Mohamed, M. F., Abdelkhalek, A., & Seleem, M. N. (2016) · Scientific Reports · doi:10.1038/srep29707 · Cited by 275
Peptoids and Polypeptoids at the Frontier of Supra- and Macromolecular Engineering
Gangloff, N., Ulbricht, J., Lorson, T., Schlaad, H., & Luxenhofer, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00201 · Cited by 265
Improved antimicrobial peptides based on acyl-lysine oligomers
Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2007) · Nature Biotechnology · doi:10.1038/nbt1309 · Cited by 256
A Current Perspective on Daptomycin for the Clinical Microbiologist
Humphries, R. M., Pollett, S., & Sakoulas, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-13 · Cited by 240
Zuckermann, R. N. (2011) · Peptide Science · doi:10.1002/bip.21573 · Cited by 238
Schmitt, M. A., Weisblum, B., & Gellman, S. H. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048546z · Cited by 232
DRAMP: a comprehensive data repository of antimicrobial peptides
Fan, L., Sun, J., Zhou, M., Zhou, J., Lao, X., Zheng, H., & Xu, H. (2016) · Scientific Reports · doi:10.1038/srep24482 · Cited by 232
Peptides and Peptidomimetics for Antimicrobial Drug Design
Mojsoska, B., & Jenssen, H. (2015) · Pharmaceuticals · doi:10.3390/ph8030366 · Cited by 229
Synergy assessed by checkerboard a critical analysis
Hsieh, M. H., Yu, C. M., Yu, V. L., & Chow, J. W. (1993) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(93)90087-n · Cited by 228
Peptoids as potential therapeutics.
Zuckermann, R. N., & Kodadek, T. J. (2009) · PubMed · Cited by 225
Schmitt, M. A., Weisblum, B., & Gellman, S. H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0666553 · Cited by 219
Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria
Arzanlou, M., Chai, W. C., & Venter, H. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160063 · Cited by 219
Antimicrobial Peptides Under Clinical Trials
E. Greber, K., & Dawgul, M. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160713143331 · Cited by 210
Mansour, S. C., de la Fuente‐Núñez, C., & Hancock, R. E. W. (2015) · Journal of Peptide Science · doi:10.1002/psc.2708 · Cited by 208
Torcato, I. M., Huang, Y.-H., Franquelim, H. G., Gaspar, D., Craik, D. J., Castanho, M. A. R. B., & Troeira Henriques, S. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.12.002 · Cited by 200
[25] Synthesis of N-substituted glycine peptoid libraries
Figliozzi, G. M., Goldsmith, R., Ng, S. C., Banville, S. C., & Zuckermann, R. N. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)67027-x · Cited by 196
Grönberg, A., Mahlapuu, M., Ståhle, M., Whately‐Smith, C., & Rollman, O. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12211 · Cited by 191
Human infection associated with methicillin-resistant Staphylococcus pseudintermedius ST71
Stegmann, R., Burnens, A., Maranta, C. A., & Perreten, V. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq241 · Cited by 188
Antibiotic resistance: A current epilogue
Dodds, D. R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.12.005 · Cited by 187
Solid-Phase Synthesis of N-Substituted Glycine Oligomers (α‑Peptoids) and Derivatives
Culf, A. S., & Ouellette, R. J. (2010) · Molecules · doi:10.3390/molecules15085282 · Cited by 180
Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria
Nawrocki, K. L., Crispell, E. K., & McBride, S. M. (2014) · Antibiotics · doi:10.3390/antibiotics3040461 · Cited by 178
Peptides and Proteins as a Continuing Exciting Source of Inspiration for Peptidomimetics
Liskamp, R. M. J., Rijkers, D. T. S., Kruijtzer, J. A. W., & Kemmink, J. (2011) · ChemBioChem · doi:10.1002/cbic.201000717 · Cited by 175
The twists and turns of β‐peptides
DeGrado, W. F., Schneider, J. P., & Hamuro, Y. (1999) · The Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00131.x · Cited by 174
Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside
Maria-Neto, S., de Almeida, K. C., Macedo, M. L. R., & Franco, O. L. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.02.017 · Cited by 173
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
Kosikowska, P., & Lesner, A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1176149 · Cited by 165
Synthetic Antimicrobial Peptidomimetics with Therapeutic Potential
Haug, B. E., Stensen, W., Kalaaji, M., Rekdal, Ø., & Svendsen, J. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701600a · Cited by 160
Membrane‐Active Small Molecules: Designs Inspired by Antimicrobial Peptides
Ghosh, C., & Haldar, J. (2015) · ChemMedChem · doi:10.1002/cmdc.201500299 · Cited by 159
Resistance to antimicrobial peptides in Gram-negative bacteria
Gruenheid, S., & Moual, H. L. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02528.x · Cited by 157
d’Angelo, I., Casciaro, B., Miro, A., Quaglia, F., Mangoni, M. L., & Ungaro, F. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.08.027 · Cited by 152
γ-AApeptides: Design, Structure, and Applications
Shi, Y., Teng, P., Sang, P., She, F., Wei, L., & Cai, J. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00492 · Cited by 152
Antifungal Activity from 14-Helical β-Peptides
Karlsson, A. J., Pomerantz, W. C. K., Weisblum, B., Gellman, S. H., & Palecek, S. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064630y · Cited by 151
Recent advances and perspectives in the design and development of polymyxins
Rabanal, F., & Cajal, Y. (2017) · Natural Product Reports · doi:10.1039/c7np00023e · Cited by 149
A Comparison of Linear and Cyclic Peptoid Oligomers as Potent Antimicrobial Agents
Huang, M. L., Shin, S. B. Y., Benson, M. A., Torres, V. J., & Kirshenbaum, K. (2011) · ChemMedChem · doi:10.1002/cmdc.201100358 · Cited by 148
Mojsoska, B., Zuckermann, R. N., & Jenssen, H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00237-15 · Cited by 139
Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B
Gallardo‐Godoy, A., Muldoon, C. A., Becker, B., Elliott, A. G., Lash, L. H., Huang, J. X., Butler, M. S., Pelingon, R., Kavanagh, A. M., Ramu, S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01593 · Cited by 138
Gebhart, D., Lok, S., Clare, S., Tomas, M., Stares, M., Scholl, D., Donskey, C. J., Lawley, T. D., & Govoni, G. R. (2015) · mBio · doi:10.1128/mbio.02368-14 · Cited by 127
Therapeutic antimicrobial peptides may compromise natural immunity
Habets, M. G. J. L., & Brockhurst, M. A. (2012) · Biology Letters · doi:10.1098/rsbl.2011.1203 · Cited by 127
A lipocentric view of peptide-induced pores
Fuertes, G., Giménez, D., Esteban-Martín, S., Sánchez‐Muñoz, O. L., & Salgado, J. (2011) · European Biophysics Journal · doi:10.1007/s00249-011-0693-4 · Cited by 123
Solid Phase Synthesis of β-Peptoids: N-Substituted β-Aminopropionic Acid Oligomers
Hamper, B. C., Kolodziej, S. A., Scates, A. M., Smith, R. G., & Cortez, E. (1998) · The Journal of Organic Chemistry · doi:10.1021/jo971675w · Cited by 123
A Randomized Double-Blind Trial of Iseganan in Prevention of Ventilator-associated Pneumonia
Kollef, M. H., Pittet, D., García, M. S., Chastre, J. E., Fagon, J.-Y., Bonten, M. J. M., Hyzy, R. C., Fleming, T. R., Fuchs, H. J., Bellm, L. A., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-656oc · Cited by 122
Characterization of Novel Antimicrobial Peptoids
Goodson, B., Ehrhardt, A. F., Ng, S., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1429 · Cited by 121
Crowther, G. S., Baines, S. D., Todhunter, S. L., Freeman, J., Chilton, C. H., & Wilcox, M. H. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks359 · Cited by 120
Righi, E., Peri, A. M., Harris, P. N. A., Wailan, A. M., Libório, M. P., Lane, S., & Paterson, D. L. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw459 · Cited by 120
Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)
van der Velden, W. J. F. M., van Iersel, T. M., Blijlevens, N. M. A., & Donnelly, J. P. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-44 · Cited by 119
Lipo-γ-AApeptides as a New Class of Potent and Broad-Spectrum Antimicrobial Agents
Niu, Y., Padhee, S., Wu, H., Bai, G., Qiao, Q., Hu, Y., Harrington, L., Burda, W. N., Shaw, L. N., Cao, C., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300274p · Cited by 117
Kaplan, C. W., Sim, J.-H., Shah, K. R., Kolesnikova-Kaplan, A., Shi, W., & Eckert, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00342-11 · Cited by 115
Advances in Peptide Pharmaceuticals
Stevenson, C. L. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109787048634 · Cited by 111
Structure and mode of action of the antimicrobial peptide arenicin
Andrä, J., Jakovkin, I., Grötzinger, J., Hecht, O., Krasnodembskaya, A. D., Goldmann, T., Gutsmann, T., & Leippe, M. (2008) · Biochemical Journal · doi:10.1042/bj20071051 · Cited by 108
Efficacy of Antimicrobial Peptoids against Mycobacterium tuberculosis
Kapoor, R., Eimerman, P. R., Hardy, J. W., Cirillo, J. D., Contag, C. H., & Barron, A. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01667-10 · Cited by 106
Nilsson, A. C., Janson, H., Wold, H., Fugelli, A., Andersson, K., Håkangård, C., Olsson, P., & Olsen, W. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03513-14 · Cited by 103
Laursen, J. S., Engel‐Andreasen, J., & Olsen, C. A. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00257 · Cited by 103
In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents
Czyzewski, A. M., Jenssen, H., Fjell, C. D., Waldbrook, M., Chongsiriwatana, N. P., Yuen, E., Hancock, R. E. W., & Barron, A. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0135961 · Cited by 102
Mojsoska, B., Carretero, G., Larsen, S., Mateiu, R. V., & Jenssen, H. (2017) · Scientific Reports · doi:10.1038/srep42332 · Cited by 97
Zhang, W., Li, Y., Qian, G., Wang, Y., Chen, H., Li, Y., Liu, F., Shen, Y., & Du, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05370-11 · Cited by 95
Hansen, T., Alst, T., Havelková, M., & Strøm, M. B. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901052r · Cited by 94
Nuri, ., Shprung, T., & Shai, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.05.022 · Cited by 90
Flemming, K., Klingenberg, C., Cavanagh, J. P., Sletteng, M., Stensen, W., Svendsen, J. S. M., & Flægstad, T. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn464 · Cited by 90
Kubicek-Sutherland, J. Z., Tomenius, H. L., Vestergaard, M. R., Hjort, K., Ingmer, H., & Andersson, D. I. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw381 · Cited by 89
Water, J. J., Smart, S., Franzyk, H., Foged, C., & Nielsen, H. M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.009 · Cited by 88
Self-citationOmiganan Pentahydrochloride in the Front Line of Clinical Applications of Antimicrobial Peptides
Melo, M. N., Dugourd, D., & Castanho, M. A. R. B. (2006) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489106777452638 · Cited by 86
Starlander, G., Börjesson, S., Grönlund-Andersson, U., Tellgren‐Roth, C., & Melhus, Å. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00703-14 · Cited by 86
Learning from Host-Defense Peptides: Cationic, Amphipathic Peptoids with Potent Anticancer Activity
Huang, W., Seo, J., Willingham, S. B., Czyzewski, A. M., Gonzalgo, M. L., Weissman, I. L., & Barron, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090397 · Cited by 84
Mishra, N. N., Yang, S., Chen, L., Muller‐Serieys, C., Saleh‐Mghir, A., Kuhn, S. M., Peschel, A., Yeaman, M. R., Nast, C. C., Kreiswirth, B. N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071151 · Cited by 84
Andreev, K., Bianchi, C., Laursen, J. S., Citterio, L., Hein-Kristensen, L., Gram, L., Kuzmenko, I., Olsen, C. A., & Gidalevitz, D. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.05.022 · Cited by 83
Olsen, C. A., Ziegler, H. L., Nielsen, H. M., Frimodt‐Møller, N., Jaroszewski, J. W., & Franzyk, H. (2010) · ChemBioChem · doi:10.1002/cbic.201000232 · Cited by 83
Self-citationMalanović, N., Leber, R., Schmuck, M., Kriechbaum, M., Cordfunke, R. A., Drijfhout, J. W., de Breij, A., Nibbering, P. H., Kolb, D., & Lohner, K. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.07.010 · Cited by 82
Tängdén, T., Adler, M., Cars, O., Sandegren, L., & Löwdin, E. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt044 · Cited by 80
Saravolatz, L. D., Pawlak, J., Johnson, L., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00194-12 · Cited by 76
Karlsson, A. J., Pomerantz, W. C. K., Neilsen, K. J., Gellman, S. H., & Palecek, S. P. (2009) · ACS Chemical Biology · doi:10.1021/cb900093r · Cited by 76
Pyrazole derived ultra-short antimicrobial peptidomimetics with potent anti-biofilm activity
Ahn, M., Gunasekaran, P., Rajasekaran, G., Kim, E. Y., Lee, S.-J., Bang, G., Cho, K., Hyun, J., Lee, H., Jeon, Y. H., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.071 · Cited by 76
Pohjala, L., Tammela, P., Samanta, S., Yli‐Kauhaluoma, J. T., & Vuorela, P. M. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.12.038 · Cited by 72
Flokas, M. E., Karageorgos, S. A., Detsis, M., Alevizakos, M., & Mylonakis, E. E. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.01.008 · Cited by 71
Helical Antimicrobial Sulfono-γ-AApeptides
Li, Y., Wu, H., Teng, P., Bai, G., Lin, X., Zuo, X., Cao, C., & Cai, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00537 · Cited by 70
Photolithographic Synthesis of Peptoids
Li, S., Bowerman, D., Marthandan, N., Klyza, S. J., Luebke, K. J., Garner, H. R., & Kodadek, T. J. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039565w · Cited by 69
Unciti‐Broceta, A., Diezmann, F., Ou-Yang, C. Y., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.02.068 · Cited by 69
Sensitization of gram‐negative bacteria by targeting the membrane potential
Goldberg, K., Sarig, H., Zaknoon, F., Epand, R. F., Epand, R. M., & Mor, A. (2013) · The FASEB Journal · doi:10.1096/fj.13-227942 · Cited by 69
Lipidated Cyclic γ-AApeptides Display Both Antimicrobial and Anti-inflammatory Activity
Li, Y., Smith, C., Wu, H., Padhee, S., Manoj, N., Cardiello, J. F., Qiao, Q., Cao, C., Yin, H. H., & Cai, J. (2013) · ACS Chemical Biology · doi:10.1021/cb4006613 · Cited by 69
Huang, M. L., Benson, M. A., Shin, S. B. Y., Torres, V. J., & Kirshenbaum, K. (2013) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201300077 · Cited by 65
Hydrophobicity and Helicity Regulate the Antifungal Activity of 14-Helical β-Peptides
Lee, M., Raman, N., Gellman, S. H., Lynn, D. M., & Palecek, S. P. (2014) · ACS Chemical Biology · doi:10.1021/cb500203e · Cited by 63
Pharmacodynamic activity of the lantibiotic MU1140
Ghobrial, O. G., Derendorf, H., & Hillman, J. D. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.028 · Cited by 62
Structure-Activity Relationships of Antibacterial Acyl-Lysine Oligomers
Radzishevsky, I. S., Kovachi, T., Porat, Y., Ziserman, L., Zaknoon, F., Danino, D., & Mor, A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.03.006 · Cited by 61
Collignon, P. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_224 · Cited by 61
γ‐AApeptides as a New Class of Peptidomimetics
Teng, P., Shi, Y., Sang, P., & Cai, J. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201504936 · Cited by 61
Combinatorial discovery process yields antimicrobial peptoids
Ng, S., Goodson, B., Ehrhardt, A. F., Moos, W. H., Siani, M., & Winter, J. A. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00132-7 · Cited by 59
Exploring the links between peptoid antibacterial activity and toxicity
Bolt, H. L., Eggimann, G. A., Jahoda, C. A. B., Zuckermann, R. N., Sharples, G. J., & Cobb, S. L. (2017) · MedChemComm · doi:10.1039/c6md00648e · Cited by 59
In Vivo Biodistribution and Small Animal PET of 64 Cu-Labeled Antimicrobial Peptoids
Seo, J., Ren, G., Liu, H., Miao, Z., Park, M., Wang, Y., Miller, T. M., Barron, A. E., & Cheng, Z. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300091d · Cited by 58
Identification of γ-AApeptides with potent and broad-spectrum antimicrobial activity
Niu, Y., Padhee, S., Wu, H., Bai, G., Harrington, L., Burda, W. N., Shaw, L. N., Cao, C., & Cai, J. (2011) · Chemical Communications · doi:10.1039/c1cc14476f · Cited by 58
AApeptides as a new class of antimicrobial agents
Niu, Y., Wu, H., Li, Y., Hu, Y., Padhee, S., Li, Q., Cao, C., & Cai, J. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob40444g · Cited by 57
Sensitization of Gram-negative bacteria to rifampin and OAK combinations
Jammal, J., Zaknoon, F., Kaneti, G., Goldberg, K., & Mor, A. (2015) · Scientific Reports · doi:10.1038/srep09216 · Cited by 55
Design and synthesis of unprecedented cyclic γ-AApeptides for antimicrobial development
Wu, H., Niu, Y., Padhee, S., Wang, R. E., Li, Y., Qiao, Q., Bai, G., Cao, C., & Cai, J. (2012) · Chemical Science · doi:10.1039/c2sc20428b · Cited by 55
Pro-Moieties of Antimicrobial Peptide Prodrugs
Forde, É., & Devocelle, M. C. (2015) · Molecules · doi:10.3390/molecules20011210 · Cited by 53
Investigational Agents for the Treatment of Gram-Negative Bacterial Infections: A Reality Check
Bush, K. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00100 · Cited by 52
Synthetic Mimics of Antimicrobial Peptides from Triaryl Scaffolds
Thaker, H. D., Sgolastra, F., Clements, D. J., Scott, R. W., & Tew, G. N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101410t · Cited by 50
Wang, P., Bang, J., Kim, H. J., Kim, J., Kim, Y., & Shin, S. Y. (2009) · Peptides · doi:10.1016/j.peptides.2009.09.020 · Cited by 49
Larsen, J., Clasen, J., Hansen, J. E., Paulander, W., Petersen, A., Larsen, A. R., & Frees, D. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-16 · Cited by 48
γ-AApeptides bind to RNA by mimicking RNA-binding proteins
Niu, Y., Jones, A. N., Wu, H., Varani, G., & Cai, J. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob05738c · Cited by 46
Chen, X., Wu, J., Luo, Y. M., Liang, X., Supnet, C. B., Kim, M. W., Lotz, G. P., Yang, G., Muchowski, P. J., Kodadek, T. J., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.06.010 · Cited by 46
Novel lysine‐peptoid hybrids with antibacterial properties
Ryge, T. S., & Hansen, P. B. (2005) · Journal of Peptide Science · doi:10.1002/psc.705 · Cited by 44
Self-citationJahnsen, R. D., Sandberg-Schaal, A., Vissing, K. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401335p · Cited by 44
Development of Tyrocidine A analogues with improved antibacterial activity
Marques, M. A., Citron, D. M., & Wang, C. C. C. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.007 · Cited by 43
Kennedy, D. (2013) · Science · doi:10.1126/science.1248056 · Cited by 42
Antiplasmodial and Prehemolytic Activities of α‐Peptide–β‐Peptoid Chimeras
Vedel, L., Bonke, G., Foged, C., Ziegler, H. L., Franzyk, H., Jaroszewski, J. W., & Olsen, C. A. (2007) · ChemBioChem · doi:10.1002/cbic.200700385 · Cited by 42
Self-citationDesign and synthesis of AApeptides: A new class of peptide mimics
Hu, Y., Li, X., Sebti, S. M., Chen, J., & Cai, J. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.005 · Cited by 42
de Mello, M. B., Malheiros, P. D. S., Brandelli, A., da Silveira, N. P., Jantzen, M. M., & da Motta, A. D. S. (2013) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-013-9125-3 · Cited by 42
Ibrahim, M. A., Panda, S. S., Oliferenko, A. A., Oliferenko, P. V., Girgis, A. S., Elagawany, M., Küçükbay, F. Z., Panda, C. S., Pillai, G. G., Samir, A., et al. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01400j · Cited by 41
Characterization of a Proteolytically Stable Multifunctional Host Defense Peptidomimetic
Jahnsen, R. D., Haney, E. F., Franzyk, H., & Hancock, R. E. W. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.007 · Cited by 41
Self-citationRaman, N., Marchillo, K., Lee, M., López, A. D. L. R., Andes, D. R., Palecek, S. P., & Lynn, D. M. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00427 · Cited by 40
Wales, S. M., Hammer, K. A., Somphol, K., Kemker, I., Schröder, D. C., Tague, A. J., Brkić, Z., King, A. M., Lyras, D., Riley, T. V., et al. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01638j · Cited by 39
Gobbo, M., Benincasa, M., Bertoloni, G., Biondi, B., Dosselli, R., Papini, E., Reddi, E., Rocchi, R., Tavano, R., & Gennaro, R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900396a · Cited by 39
Liu, Y., Knapp, K. M., Yang, L., Molin, S., Franzyk, H., & Folkesson, A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.014 · Cited by 39
Self-citationDiscovery and development of surotomycin for the treatment of Clostridium difficile
Knight-Connoni, V., Mascio, C. T. M., Chesnel, L., & Silverman, J. A. (2015) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-015-1714-6 · Cited by 39
Domalaon, R., Findlay, B., Ogunsina, M. O., Arthur, G., & Schweizer, F. (2016) · Peptides · doi:10.1016/j.peptides.2016.07.007 · Cited by 39
β‐peptoid “Foldamers”—Why the additional methylene unit?
Olsen, C. A. (2010) · Biopolymers · doi:10.1002/bip.21571 · Cited by 38
γ-AApeptide-based small-molecule ligands that inhibit Aβ aggregation
Wu, H., Li, Y., Bai, G., Niu, Y., Qiao, Q., Tipton, J. D., Cao, C., & Cai, J. (2013) · Chemical Communications · doi:10.1039/c3cc46685j · Cited by 37
Antiplasmodial Activity of Lauryl-Lysine Oligomers
Radzishevsky, I. S., Krugliak, M., Ginsburg, H., & Mor, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-06 · Cited by 37
Protein Side-Chain Translocation Mutagenesis via Incorporation of Peptoid Residues
Lee, B.-C., & Zuckermann, R. N. (2011) · ACS Chemical Biology · doi:10.1021/cb200300w · Cited by 37
Luo, Y., Bolt, H. L., Eggimann, G. A., McAuley, D. F., McMullan, R., Curran, T., Zhou, M., Jahoda, P. C. A. B., Cobb, S. L., & Lundy, F. T. (2016) · ChemBioChem · doi:10.1002/cbic.201600381 · Cited by 36
Falciani, C., Lozzi, L., Scali, S., Brunetti, J., Bracci, L., & Pini, A. (2014) · Amino Acids · doi:10.1007/s00726-014-1686-2 · Cited by 35
Makobongo, M. O., Gancz, H., Carpenter, B. M., McDaniel, D. P., & Merrell, D. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00689-11 · Cited by 35
Hein-Kristensen, L., Knapp, K. M., Franzyk, H., & Gram, L. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-144 · Cited by 34
Self-citationInvestigating the Anti‐leishmanial Effects of Linear Peptoids
Eggimann, G. A., Bolt, H. L., Denny, P. W., & Cobb, S. L. (2014) · ChemMedChem · doi:10.1002/cmdc.201402416 · Cited by 33
Zhu, W., Hahm, K., & Shin, S. Y. (2007) · Journal of Peptide Science · doi:10.1002/psc.882 · Cited by 33
Raman, N., Lee, M., López, A. D. L. R., Palecek, S. P., & Lynn, D. M. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.07.016 · Cited by 33
Raman, N., Lee, M., Lynn, D. M., & Palecek, S. P. (2015) · Pharmaceuticals · doi:10.3390/ph8030483 · Cited by 32
Epand, R. F., Mor, A., & Epand, R. M. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0711-9 · Cited by 32
OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria
Livne, L., Epand, R. M., Papahadjopoulos‐Sternberg, B., Epand, R. M., & Mor, A. (2010) · The FASEB Journal · doi:10.1096/fj.10-167809 · Cited by 31
Cadazolid for the treatment of Clostridium difficile
Endres, B. T., Bassères, E., Alam, M. J., & Garey, K. W. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1304538 · Cited by 31
Discovery and Characterization of a Peptoid with Antifungal Activity against Cryptococcus neoformans
Corson, A. E., Armstrong, S. A., Wright, M. E., McClelland, E. E., & Bicker, K. L. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00338 · Cited by 30
Radiolabeled γ-AApeptides: a new class of tracers for positron emission tomography
Yang, Y., Niu, Y., Hong, H., Wu, H., Zhang⋆, Y., Engle, J. W., Barnhart, T. E., Cai, J., & Cai, W. (2012) · Chemical Communications · doi:10.1039/c2cc33620k · Cited by 28
Hein-Kristensen, L., Franzyk, H., Holch, A., & Gram, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073620 · Cited by 27
Self-citationA Novel Trp-rich Model Antimicrobial Peptoid with Increased Protease Stability
Bang, J. K., Nan, Y. H., Lee, E.-K., & Shin, S.-Y. (2010) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2010.31.9.2509 · Cited by 26
Design and Characterization of a Broad -Spectrum Bactericidal Acyl-lysyl Oligomer
Livne, L., Kovachi, T., Sarig, H., Epand, R. F., Zaknoon, F., Epand, R. M., & Mor, A. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.11.012 · Cited by 26
Rapid Access to Multiple Classes of Peptidomimetics from Common γ‐AApeptide Building Blocks
Wu, H., Teng, P., & Cai, J. (2014) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201301841 · Cited by 25
Tal‐Gan, Y., Freeman, N. S., Klein, S., Levitzki, A., & Gilon, C. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.02.031 · Cited by 25
Stiefel, U., Pultz, N. J., Helfand, M. S., & Donskey, C. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2144-2148.2004 · Cited by 23
Skovbakke, S. L., Heegaard, P. M. H., Larsen, C. J., Franzyk, H., Forsman, H. F., & Dahlgren, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.11.004 · Cited by 22
Self-citationPadhee, S., Li, Y., & Cai, J. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.039 · Cited by 22
Epand, R. F., Sarig, H., Ohana, D., Papahadjopoulos‐Sternberg, B., Mor, A., & Epand, R. M. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp111242q · Cited by 21
Structure and Function of AApeptides
Bolarinwa, O., Nimmagadda, A., Su, M., & Cai, J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b01132 · Cited by 21
Experimental Conditions That Enhance Potency of an Antibacterial Oligo-Acyl-Lysyl
Goldfeder, Y., Zaknoon, F., & Mor, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01656-09 · Cited by 20
Lin, H., Yan, T., Wang, L., Guo, F., Ning, G., & Xiong, M. (2016) · Journal of Chemometrics · doi:10.1002/cem.2801 · Cited by 20
Regulatory Incentives for Antibiotic Drug Development: A Review of Recent Proposals
Sinha, M. S., & Kesselheim, A. S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.08.033 · Cited by 20
Srinivas, N., Moehle, K., Abou‐Hadeed, K., Obrecht, D., & Robinson, J. A. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b706370a · Cited by 19
Simultaneous breakdown of multiple antibiotic resistance mechanisms in S. aureus
Kaneti, G., Sarig, H., Marjieh, I., Zaknoon, F., & Mor, A. (2013) · The FASEB Journal · doi:10.1096/fj.13-237610 · Cited by 19
Synthesis of DNA-Binding Peptoids
Bong, D. T.-Y., & Mao, J. (2015) · Synlett · doi:10.1055/s-0034-1380698 · Cited by 19
Solid-Phase Synthesis of γ-AApeptides Using a Submonomeric Approach
Wu, H., Amin, M. N., Niu, Y., Qiao, Q., Harfouch, N., Nimer, A., & Cai, J. (2012) · Organic Letters · doi:10.1021/ol301406a · Cited by 19
Watkins, R., Smith, T. C., & Bonomo, R. A. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1216314 · Cited by 19
Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity
Ahn, M., Jacob, B., Gunasekaran, P., Murugan, R. N., Ryu, E. K., Lee, G.-H., Hyun, J., Cheong, C., Kim, N., Shin, S. Y., et al. (2014) · Amino Acids · doi:10.1007/s00726-014-1778-z · Cited by 18
Mora‐Navarro, C., Caraballo‐León, J., Torres‐Lugo, M., & Ortiz‐Bermúdez, P. (2015) · Journal of Peptide Science · doi:10.1002/psc.2827 · Cited by 18
Lipidated α-Peptide/β-Peptoid Hybrids with Potent Anti-inflammatory Activity
Skovbakke, S. L., Larsen, C. J., Heegaard, P. M. H., Moesby, L., & Franzyk, H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501341h · Cited by 17
Self-citationSarig, H., Goldfeder, Y., Rotem, S., & Mor, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00666-10 · Cited by 17
Carboxyalkyl peptoid PNAs: synthesis and hybridization properties
Cola, C. D., Manicardi, A., Corradini, R., Izzo, I., & Riccardis, F. D. (2012) · Tetrahedron · doi:10.1016/j.tet.2011.11.017 · Cited by 16
Cited by
The global preclinical antibacterial pipeline
Theuretzbacher, U., Outterson, K., Engel, A., & Karlén, A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0288-0 · Cited by 738
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 567
Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era
Wang, J., Dou, X., Song, J., Lyu, Y., Zhu, X., Xu, L., Li, W., & Shan, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21542 · Cited by 547
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Antimicrobial peptides as therapeutic agents: opportunities and challenges
Mahlapuu, M., Björn, C., & Ekblom, J. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1796576 · Cited by 484
Metadata
- Authors
- Molchanova, N., Hansen, P., & Franzyk, H.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-08-29
- Volume
- 22
- Issue
- 9
- Pages
- 1430
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2752567037
- Cited by
- 257
- References
- 207
- FWCI
- 18.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.